Plain-English translation of NCT06907446 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Prostate biopsies are a standard way to detect prostate cancer by collecting small tissue samples from the prostate gland. This study is testing whether a new biopsy needle called the SUREcore 18g needle can collect better-quality tissue samples compared to the standard needle currently used. The goal is to see if this new needle improves doctors' ability to detect and understand prostate cancer.
Current biopsy needles sometimes miss cancer or don't collect enough tissue to give doctors a complete picture. The new treatment is designed to collect more complete tissue cores with the same needle size, which could help doctors catch prostate cancer more accurately and avoid repeat biopsies.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo a prostate biopsy using one of the two needle systems being compared. During the procedure, your doctor will use the assigned needle to collect small tissue samples from your prostate gland. The study will then compare how much tissue each needle type collected and how well it helped detect prostate cancer. The biopsy itself is a routine procedure, but this study is examining whether the new needle performs better than the standard option.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States
Sponsor
University of California, Davis
Enrollment target
~50 participants
Started
May 2025
Primary completion
July 2027
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in July 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Marc Dall'Era, MD
University of California, Davis
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.